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Background: Acute coronary syndromes may manifest as ST-Elevation Myocardial Infarction (STEMI) or Non-ST Elevation Myocardial Infarction 
(NSTEMI). Although patients who present with STEMI or NSTEMI share the same cardiac risks factors, is it not clear in the literature if STEMI patients 
have a better or worse prognosis than NSTEMI patients, both on a short and long term perspective.
methods: We performed a systematic review and meta-analysis of all observational studies that compared the short and long term clinical 
outcomes of STEMI vs NSTEMI patients. In the search criteria, we restricted to publications later than 2000, as the definition was more consistent 
thereafter. The 30-day post-myocardial infarction (MI) mortality was selected as the short-term outcome, and 6-12 months post-MI was chosen as 
the long-term outcome. In the studies, all factors that could influence prognosis were recorded, including cardiac risk factors, Killip class, time to 
presentation, door to balloon delays. Mortality data were pooled using random-effects model. All factors recorded were examined to see if they were 
related to mortality, using meta-regression and sensitivity analysis.
results: A total of 23 studies involving 52,441 patients met our inclusion criteria. All were retrospective cohort studies. At 30 days, STEMI was 
associated with a higher mortality compared to NSTEMI (OR = 1.55, 95% CI [1.16 - 2.06] p = 0.00025). In the meta-regression, none of the factors 
examined was associated with increased risk. At one year, STEMI and NSTEMI shared similar mortality risks (OR = 1.02, 95% IC [0.8 - 1.3] p = 
0.8478). In the meta-regression, the only factor associated with increased risk was age (p=0.013).
conclusions: In this meta-analysis, the first to compare short and long term mortality in STEMI and NSTEMI patients, both types of ACS share a 
similar long-term prognosis, despite a worse short-term prognosis after STEMI. Younger age in STEMI is a factor related to better long-term prognosis.
